iifl-logo

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

Max Healthcare Sees 22% Revenue Surge with New Facilities and Strategic Expansions

7 Nov 2024 , 10:52 PM

Max Healthcare Institute Ltd. reported 22% YoY revenue growth for the quarter ending September 2024, driven by higher operational bed days (OBDs) and an increase in average revenue per occupied bed (ARPOB).

The average revenue per occupied bed rose to ₹76,100, up 2% from ₹74,600 in the same quarter last year. Total revenue for the quarter reached ₹2,228 Crore, reflecting a 10% increase from the previous quarter.

Operating EBITDA was ₹566 Crore, excluding an ₹18 Crore loss from the new MSSH Dwarka facility and ₹7 Crore in transaction expenses related to the Jaypee Hospital acquisition. Net profit (PAT) rose to ₹349 Crore, up from ₹338 Crore in Q2FY24. Excluding losses from MSSH Dwarka, PAT was ₹375 Crore.

In October, Max Healthcare acquired a 63.65% stake in Jaypee Healthcare Ltd, adding a 500-bed tertiary hospital in Noida and a secondary care facility in Bulandshahr to its network. The new 303-bed MSSH Dwarka facility, launched in July 2024, began serving South West Delhi with comprehensive tertiary and quaternary care services.

Chairman and Managing Director Abhay Soi noted the expansion strengthens Max Healthcare’s patient-centric care offerings in NCR and, with planned expansions set for FY26, will further broaden their healthcare reach and capabilities.

Related Tags

  • max Heal
  • Max Healthcare
  • Max Healthcare news
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.